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Abstract Nitric oxide (NO') can induce transient [Ca ] 
changes in endothelial cells not different from receptor mediated 
signalling. Whether this Ca2+ signal may provide a link with IL-8 
secretion induced by NO' donors was investigated in human 
endothelial cells. Sodium nitroprusside (SNP) and S-nitroso-A'-
acetyl-DL-penicillamine (SNAP) dose dependently increased IL-8 
production in this cell type. Additive IL-8 secretion was found 
with TNFa. Buffering intracellular Ca2+ with MAPT/AM 
suppressed NO* induced [Ca2+]¡ changes and reduced subsequent 
IL-8 secretion. The additive effect of both NO" donors on TNFa 
induced IL-8 secretion was completely blocked in the presence of 
MAPT/AM. SKF 96365, which has been shown to block 
receptor mediated Ca2+ entry, and TMB-8, which blocks 
intracellular Ca2+ release, both inhibited IL-8 secretion, 
particularly when TNFa was used as a costimulator, indicating 
that [Ca2+1¡ changes are important components of IL-8 induction 
by NO'. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Interleukin 8 (IL-8) is a neutrophil chemoattractant pro-
duced from a variety of cells including monocytes and endo-
thelial cells [1]. Increased plasma and cell associated levels of 
this cytokine were found in patients suffering from sepsis, 
trauma and acute respiratory distress syndrome [2,3]· More-
over, the application of anti-IL-8 provided significant protec-
tion in several animal models of these diseases [4,5]. Together 
with IL-8 an increased production of nitric oxide has also 
been recognized in the same pathological states [6-8]. The 
potential of nitric oxide to induce IL-8 gene transcription 
has recently been demonstrated [9-12]. However, the mecha-
nisms have not been addressed. Several reports led us to hy-
pothesize that cytoplasmic [Ca2+] changes may provide a link 
for these observations. Ca2+ ionophores like A23187 and ion-
omycin induce or augment IL-8 secretion in different cell 
types [13,14]. Recently we have shown that nitric oxide is 
able to induce transient [Ca2+]¡ changes in endothelial cells 
similar to receptor mediated changes proximal or at the IP3 
receptor [15]. We therefore investigated whether [Ca2+]¡ 
changes induced by NO' donors contribute to IL-8 production 
in endothelial cells. 
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Abbreviations: IL-8, interleukin 8; TNFa, tumor necrosis factor a; 
SNAP, S-nitroso-TV-acetyl-DL-penicillamine; SNP, sodium nitroprus-
side 
2. Materials and methods 
2.1. Cell culture 
Human endothelial cell line ECV304 (ECACC, Cerdic, Sophia 
Antipolis, France) was cultured in RPMI medium (Sigma, Deisenho-
fen, Germany) at 37°C (21% 02/5% C02), supplemented with fetal 
calf serum (10%, Sigma), glutamine (2 mM, Gibco, Eggenstein, Ger-
many), penicillin (100 U/ml, Sigma), streptomycin (100 μg/ml), and 
grown in culture flasks (Falcon, Heidelberg, Germany). 
2.2. [Ca2+]i and IL-8 measurements 
[Ca2+]i measurements were performed in buffer which consisted of 
127 mM NaCl, 5 mM KC1, 2 mM MgCl2, 0.5 mM NaH2P04, 10 mM 
D-glucose, pH 7.3, plus 1.8 mM CaCl2. Subconfluent cells growing on 
glass coverslips were rinsed 4 times with buffer. [Ca2+]¡ was measured 
in single cells loaded for 30 min with 1 μΜ of the calcium sensitive 
probe FURA-2/AM (Molecular Probes, Eugene, OR, USA) dissolved 
in dimethylformamide. For cell imaging a digital analysis system 
(T.I.L.L. photonics, Planegg, Germany) connected to an inverted mi-
croscope (DMIRB, Leica) equipped with a Zeiss Fluar 40X/1.30 oil 
objective was used. Excitation wavelengths (340 nm, 380 nm) were 
produced by a scanning monochromator and images of fluorescence 
passing a 395 nm dichroic mirror and a 520 ± 10 nm band pass filter 
were recorded by a cooled slow scan CCD camera at a rate of 2 Hz. 
Given are data for fluorescence ratio values (excitation 340 nm/380 
nm) [15,16]. For the measurement of IL-8 cells were cultured for 24 h 
in 96 multiwell plates (Falcon). IL-8 in the supernatant was measured 
using a commercially available ELISA (Milenia, DPC, Bad Nauheim, 
Germany). 
2.3. Cytotoxicity assay 
S-Nitroso-iV-acetyl-DL-penicillamine (SNAP; Calbiochem, Ger-
many), sodium nitroprusside (SNP; Merck, Darmstadt, Germany) 
up to the highest concentrations used in this study (1 mM), SKF 
96365 (Calbiochem-Novabiochem, Bad Soden/Ts., Germany), TMB-
8 (Calbiochem-Novabiochem), MAPT/AM (Molecular Probes) did 
not result in increased trypan blue uptake compared to control cells 
to indicate viability [17]. 
2.4. Statistical analysis 
To compare the measured results in different groups descriptive 
statistical parameters (mean ± S.E.M.) were calculated and differences 
were tested for significance using an ANOVA. The Student-Newman-
Keuls test was used to compare individual results with the control. P 
values < 0.05 were considered to be significant. 
3. Results 
3.1. Nitric oxide donors induce transient [Ca2+]i changes in 
endothelial cells 
In a previous study, we showed that NO* donors transiently 
increase [Ca2+]¡ in endothelial cells indistinguishable from re-
ceptor mediated changes [15]. This transient increase upon 
addition of both SNP (100 μΜ; increase in fluorescence ratio 
units from 34.8±4.2 to 163.6± 16.7; P<0.001) and SNAP 
(100 μΜ; peak fluorescence ratio units: 174.0± 10.7 com-
pared to baseline levels of 35.7 ±4.3; P< 0.001) (Fig. 1A,B) 
is prevented in the presence of MAPT/AM (15 μΜ; 
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Fig. 1. [Ca2+]i changes in single endothelial cells induced by nitric oxide donors and TNFcx. A,B: Cells were treated with SNP (100 μΜ) or 
SNAP (100 μΜ) as indicated by the arrow and FURA-2 signals were recorded in at least six cells simultaneously. C,D: Cells were pretreated 
with MAPT/AM (15 μΜ) for 15 min and stimulated with SNP (100 μΜ) or SNAP (100 μΜ) as in A,B. Represented are typical measurements 
of four independent experiments in each setting. E: Influence of long term exposure of endothelial cells with SNP (100 μΜ; o) , TNF (10 ng/ 
ml; Δ), SNP+TNF ( v ) , SNP+MAPT/AM (15 μΜ; ■), TNF+MAPT/AM ( A ) , TNF+SNP+MAPTAM (▼). SNP (100 μΜ) short time treat-
ment (O) is shown in comparison. Symbols represent means ± S.E.M. of experiments performed in triplicate. 
P< 0.001) (Fig. 1C,D). [Ca2+]¡ levels of unpretreated cells 
stimulated with SNP (100 μΜ) or SNAP (100 μΜ) return 
to baseline within 5-10 min and incubations with SNP (100 
μΜ), SNAP (100 μΜ), TNFoc (10 ng/ml), M A P T / A M (15 
μΜ) and combinations thereof did not induce any increased 
[Ca2+]i levels up to 24 h in the continuous presence of these 
substances (Fig. IE). 
3.2. NOT donating drugs induce secretion of IL-8 
IL-8 secretion from E C V 304 cells was measured in the 
supernatant after 24 h of incubation with N O ' donat ing 
agents in the presence or absence of oxyhemoglobin to scav-
enge nitric oxide. SNP (10 μ Μ - l m M ) and SNAP (10 μ Μ - 1 
m M ) induced a concentration dependent secretion of IL-8 
(compared to untreated controls P< 0.001 for 100 μ Μ and 
1 m M for both substances; Fig. 2). Since we were able to 
show previously that concentrations of S N P above 5 m M 
and S N A P above 1 m M cause toxic damage to our cells 
[17] in all further experiments we used 100 μ Μ of both N O ' 
donors . In the presence of oxyhemoglobin (50 μ Μ ) IL-8 se-
cretion was not different from untreated control cells for both 
SNP (100 μΜ) and S N A P (100 μΜ) indicating that N O ' was 
the primary mediator (Fig. 2). 
3.3. Secretion induced by TNFa is enhanced by N(J donating 
agents 
T N F a induced IL-8 secretion in endothelial cells after 24 h 
(3366 ±568 pg/ml) was found to be stronger than IL-8 
secretion induced by either 100 μ Μ SNP (2892 ± 397 pg/ml) 
or 100 μ Μ S N A P (2156 ±255 pg/ml). However, simultaneous 
administration of either S N P plus T N F a or S N A P plus 
T N F a increased IL-8 production by endothelial cells 
(4702 ± 3 9 2 pg/ml and 5439 ± 2 1 0 pg/ml, respectively) 
(Fig. 3). 
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3.4. Role of [Ca2+]i in IL-8 secretion induced by NO' donors 
Whether [Ca2+]¡ changes induced by SNP or SNAP con-
tribute to IL-8 secretion was tested in the presence of the Ca2+ 
buffer MAPT/AM. In this series the induction of IL-8 secre-
tion after 24 h by 100 μΜ SNP (3122 ±465 pg/ml) was only 
marginally reduced in the presence of MAPT/AM (2882 ± 526 
pg/ml) whereas secretion induced by 100 μΜ SNAP 
(2156 ±255 pg/ml) was reduced in the presence of MAPT7 
AM (1327 ±194 pg/ml; P<0.05) . However, IL-8 production 
induced by combined treatment with 10 ng/ml TNFa plus 100 
μΜ SNP (4616 ±470 pg/ml) or 10 ng/ml TNFa plus 100 μΜ 
SNAP (4322 ± 503 pg/ml) was significantly reduced to baseline 
production in the presence of MAPT/AM (1635 ±136 pg/ml 
and 1466 ±205 pg/ml, P<0 .01 each, respectively) (Fig. 4A). 
Drugs inhibiting Ca2+ release from intracellular stores (TMB-
8) [18] or receptor mediated capacitative Ca2+ entry (SKF 
96365) [19] were also tested. In these series the presence of 
TMB-8 decreased SNP (100 μΜ) induced IL-8 secretion from 
3122 ±465 pg/ml to 758 ±44 pg/ml (P<0.05) and secretion 
induced by 100 μΜ SNP plus 10 ng/ml TNFa from 
4616 ±470 pg/ml to 956 ± 153 pg/ml (P<0.01). The presence 
of SKF also reduced SNP (100 μΜ) induced IL-8 secretion to 
1704 ±357 pg/ml (P<0.05) and SNP (100 μΜ) plus TNFa 
(10 ng/ml) induced IL-8 secretion to 1970 ±525 pg/ml 
(P<0.05) (Fig. 4B). 
4. Discussion 
6000 
Fig. 3. NO' donors increase IL-8 production induced by TNF. SNP 
(100 μΜ), SNAP (100 μΜ) and TNF (10 ng/ml) were added to en-
dothelial cell cultures as indicated. The graph represents mean± 
S.E.M. values of supernatant IL-8 of three independent experiments 
performed in duplicate. 
Several groups demonstrated the potential of nitric oxide to 
regulate proinflammatory cytokine expression [20-23]. In par-
ticular, IL-8 expression may well be supported by NO' over-
production in vivo [6]. This cytokine has also been reported to 
4000 
3000 
I 
2000 
1000 
I Z t < Z 
t 
Fig. 2. IL-8 production from endothelial cells stimulated with NO' 
donors. Endothelial cells were stimulated with the indicated substan-
ces for 24 h. Shown are mean ± S.E.M. values of supernatant IL-8 
of three independent experiments performed in duplicate. 
be inducible by Ca2+ ionophores like A23187 and ionomycin 
[13,14]. Intracellular [Ca2+] changes have long been known to 
control stimulus-secretion coupling. However, participation in 
proinflammatory gene transcription has also been demon-
strated [24]. For example, LPS induced IL-1 secretion has 
been shown to be Ca2+ dependently regulated [25]. Moreover, 
Ca2+ dependent gene transcription in neuronal cells has been 
reported to be enhanced by NO' [26]. [Ca2+]¡ changes may 
therefore serve as a critical link in NO' mediated IL-8 secre-
tion. In a previous study we demonstrated that nitric oxide 
induces transient [Ca2+]¡ changes similar to receptor mediated 
changes in endothelial cells [15]. In the present study we show 
that transient [Ca2+]¡ changes induced by NO' donors may 
provide at least part of the signal for IL-8 secretion. Induction 
of IL-8 by two different NO' donating agents was blocked by 
pre-incubation with oxyhemoglobin, the most important pro-
teinaceous trap of NO' in vivo [27]. Likewise, [Ca2+]¡ changes 
induced by these NO' donors were also blocked by oxyhemo-
globin as has been demonstrated previously [15]. Experiments 
using MAPT/AM to buffer intracellular Ca2+ ions inhibited 
[Ca2+]i changes but IL-8 secretion was only marginally re-
duced in the case of SNP, whereas SNAP induced IL-8 secre-
tion was completely suppressed. However, IL-8 production 
induced by both NO' donors in TNFa treated cells was 
most effectively blocked in the presence of MAPT/AM. Inhib-
ition of Ca2+ release from intracellular stores by TMB-8 and 
inhibition of Ca2+ entry by SKF 96365 also reduced IL-8 
secretion in SNP and TNFa plus SNP treated cells. In con-
clusion these results indicate that NO' induced [Ca2+]¡ changes 
may serve as a critical signal for IL-8 secretion, particularly in 
the presence of TNFa. Whether drugs affecting Ca2+ regula-
tion are of benefit in complex situations where proinflamma-
tory cytokines and nitric oxide are overproduced awaits fur-
ther investigation [28]. 
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Fig. 4. Influence of drugs affecting [Ca2+] regulation on NO' donor 
induced IL-8 secretion from endothelial cells. A: Cells were treated 
for 24 h with SNP (100 μΜ; crosshatched bars) or SNAP (black 
bars) in the presence of TNF (10 ng/ml) and/or MAPT/AM as indi-
cated. B: Cells were treated with SNP (100 μΜ), TNF (10 ng/nl), 
SKF 96365 (50 μΜ), and TMB-8 (100 μΜ) for 24 h as indicated. 
The graph represents mean ± S.E.M. values of supernatant IL-8 of 
two independent experiments performed in duplicate. 
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